Write in a clean editor, then format for Kidney and Dialysis in one click — DocuGuru applies the official MDPI template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Kidney and Dialysis is a peer-reviewed journal published by MDPI, covering Dialysis and Renal Disease Management, Central Venous Catheters and Hemodialysis, Chronic Kidney Disease and Diabetes. Over its lifetime it has published 244 papers, which have received 894 citations.
| Publisher | MDPI |
|---|---|
| Reference style | Numbered (MDPI) Numbered — [1], [2] in the text 1. Smith, A.; Jones, B.; Lee, C. A Representative Article Title. Kidney and Dialysis 2023, 12, 45–58.
Formats any DOI in Kidney and Dialysis style. No sign-up. |
| Abbreviation (ISO-4) | Kidney Dial. |
| Publishes research in | Dialysis and Renal Disease Management Central Venous Catheters and Hemodialysis Chronic Kidney Disease and Diabetes Electrolyte and hormonal disorders Acute Kidney Injury Research |
| ISSN | 2673-8236 |
| Citation impact (2-yr) | 1.06 |
| h-index | 13 |
| i10-index | 19 |
| Open access | Yes — indexed in DOAJ |
| Top institutions publishing here | Ghent University Hospital |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Globally, the incidence and prevalence of diabetes mellitus has risen dramatically, owing mainly to the increase in type 2 diabetes mellitus (T2DM). In 2021, 537 million people worldwide (11% of the global population) had diabetes, and this number is expected to increase to 783 million (12%) by 2045. The growing burden of T2DM is secondary…
The importance of patient activation (i.e., the knowledge, skills, and confidence one has in managing one's own healthcare) in people with long-term conditions, including kidney disease, is growing. Enabling and empowering patients to take a more active role in their health and healthcare is the focus of person-centred care. Patient activation is recognised as a…
Renal fibrosis is a hallmark of end-stage chronic kidney disease. It is characterized by increased accumulation of extracellular matrix (ECM), which disrupts cellular organization and function within the kidney. Here, we review the bi-directional interactions between cells and the ECM that drive renal fibrosis. We will discuss the cells involved in renal fibrosis, changes that…
Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited cause of renal failure and has limited pharmacological treatment options. Disease progression is relentless, and regression is not a known feature of ADPKD even with pharmacological intervention. Recent research has uncovered underlying pathogenic mechanisms that may be amenable to dietary interventions. Cyst cells in…
SGLT2 inhibitors can protect the kidneys of patients with and without type 2 diabetes mellitus and slow the progression towards end-stage kidney disease. Blocking tubular SGLT2 and spilling glucose into the urine, which triggers a metabolic counter-regulation similar to fasting, provides unique benefits, not only as an anti-hyperglycemic strategy. These include a low hypoglycemia risk…
